A new trading day began on Tuesday, with Rocket Pharmaceuticals Inc (NASDAQ: RCKT) stock price up 5.56% from the previous day of trading, before settling in for the closing price of $3.6. RCKT’s price has ranged from $2.19 to $11.45 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -11.60%. Meanwhile, its annual earnings per share averaged 24.90%. With a float of $99.60 million, this company’s outstanding shares have now reached $108.21 million.
Rocket Pharmaceuticals Inc (RCKT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rocket Pharmaceuticals Inc is 7.96%, while institutional ownership is 86.13%. The most recent insider transaction that took place on Jan 02 ’26, was worth 34,400. In this transaction Director of this company bought 10,000 shares at a rate of $3.44, taking the stock ownership to the 50,000 shares. Before that another transaction happened on Nov 18 ’25, when Company’s insider sold 2,545 for $2.98, making the entire transaction worth $7,592. This insider now owns 299,064 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.62 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.89% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Here are Rocket Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.56 in one year’s time.
